GL1X · GenesisL1 explorer

MolNFT v1 · #138950 · protein

Crystal structure of the FLT3 kinase domain bound to the inhibitor ff- 10101

5X02 · Receptor-type tyrosine-protein kinase FLT3: “Crystal structure of the FLT3 kinase domain bound to the inhibitor ff- 10101”. X-ray diffraction, 2 ligands (F6M, SO4), 4 pockets (best druggability 0.68). MolNFT v1 #138950 on GenesisL1…

PDB
5X02
Type
protein
Length
305 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Receptor-type tyrosine-protein kinase FLT3
EC
2.7.10.1
UniProt
P36888
Ligands
F6M, SO4
Pockets
4 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReceptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1)protein30536% helix, 22% strandP36888

Ligands and binding sites

  • F6M · N-[(2S)-1-[5-[2-[(4-cyanophenyl)amino]-4-(propylamino) pyrimidin-5-yl]pent-4-ynylamino]-1-oxidanylidene-propan-2-yl]-4-(dimethylamino)-N-methyl-but-2-enamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12330.680.8437F6M
21540.490.7823empty
3740.440.8115empty
4750.360.7717empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5X02 · Crystal structure of the FLT3 kinase domain bound to the inhibitor FF-10101 · the same entry in another collection · chain A against A, TM-score 1.00
  • P36888 · AlphaFold monomer V2.0 prediction for receptor-type tyrosine-protein kinase FLT3 (P36888) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.